TOFACITINIB CITRATE

Clinical safety rating: avoid

Strong CYP3A4 inhibitors may increase levels Can cause serious infections and increased risk of malignancy.

How it works

Mechanism information is still being processed. Check the DailyMed link in the sidebar for the official prescribing information.

Tablet 5 mg - Oral

Dosage form	TABLET
Renal impairment	Consult protocols for adjustment.
Liver impairment	Consult protocols for adjustment.

Clinical note

Strong CYP3A4 inhibitors may increase levels Can cause serious infections and increased risk of malignancy.

FDA category

Category Contraindicated

Upper respiratory infection

Loading safety data…

Clinical safety rating: avoid

Strong CYP3A4 inhibitors may increase levels Can cause serious infections and increased risk of malignancy.

Mechanism information is still being processed. Check the DailyMed link in the sidebar for the official prescribing information.

Tablet 5 mg - Oral

Dosage form	TABLET
Renal impairment	Consult protocols for adjustment.
Liver impairment	Consult protocols for adjustment.

Clinical note

Strong CYP3A4 inhibitors may increase levels Can cause serious infections and increased risk of malignancy.

FDA category

Category Contraindicated

Upper respiratory infection

Loading safety data…